Start a conversation

Proposed environment 03

Advanced Medicines Manufacturing

Turn process learning into controlled and scalable transfer.

Illustrative concept visualActive predevelopmentProposed, not built
View depthCutaway
ExteriorInterior
Illustrative concept visual. No site, building, equipment, operating capability or delivery date is approved or represented as existing.
01
Proposed campus role

Translate product knowledge into process understanding and transfer requirements.

02
Decision the concept could support

Whether to configure internal capability, use a qualified manufacturer, redesign or stop.

03
Potential value

Lower transfer risk and more disciplined capacity decisions.

Proposed purpose

Designed around an evidence journey, not a catalogue of rooms.

The proposed building would be designed around process development, pilot learning and controlled transfer rather than speculative production capacity. Its intended role would be to test how formulation, equipment, controls, packaging and logistics might interact before any larger manufacturing commitment.

Illustrative zones

  • Process development
  • Modular clean environment
  • Process control
  • Packaging concept
  • Secure logistics

Where value could be created

Manufacturing value begins with process knowledge, not floor area.

The proposed environment could expose process and transfer dependencies before capital was committed to larger capacity. A modular approach could preserve options by allowing process areas to proceed only when product scope, demand, operator responsibility, quality requirements and licensing routes justified them.

  1. 01

    Prove manufacturability

    Process studies could reveal how material, equipment and operating conditions affect intended product quality.

    Potential outputA defined process knowledge package
  2. 02

    Expose scale risk

    Small scale models and engineering work could identify mixing, hold, filtration, filling, cleaning and utility questions earlier.

    Potential outputA scale and transfer risk register
  3. 03

    Sequence capital

    Common infrastructure and product-specific modules could be separated so capacity follows credible demand.

    Potential outputA staged capacity recommendation
  4. 04

    Strengthen future transfer

    Parameters, controls, records and packaging requirements could be organised for a qualified receiving organisation.

    Potential outputA controlled technology transfer package
Operating thesis

Capital should follow evidence, repeat demand and accountable delivery. The building would not advance merely because the concept is visually compelling.

Illustrative proposed activities

Inside the science.

How laboratory knowledge could become a repeatable process.

These examples describe proposed process development activities. Any pilot batch, engineering batch or medicine manufacture would depend on product classification, operator responsibility, quality systems, licences and approvals.

01
Activity

Unit operation characterisation

What happens

Teams could study mixing, hold time, filtration, drying, filling, compression, coating or another relevant operation for a defined product.

Illustrative system categories

Bench scale process equipment, load cells, temperature and pressure sensors, sampling tools and controlled records.

Potential decision output

Proposed parameter ranges and the risks requiring further study.

Equipment and containment would depend on dosage form, material hazard, batch scope and qualified oversight.
02
Activity

Scale model and process simulation

What happens

Teams could compare process behaviour across scales and model material flow, heat transfer, mixing or facility demand.

Illustrative system categories

Scale representative vessels, process modelling, flow simulation, mass balance tools and utility models.

Potential decision output

A scale rationale with assumptions, confidence and engineering questions.

Simulation would support human engineering judgement and would require confirmation against suitable physical evidence.
03
Activity

Process monitoring strategy

What happens

Teams could evaluate which measurements, sampling points, alarms and review steps might show whether a process remains controlled.

Illustrative system categories

Process sensors, spectroscopy, environmental monitoring, electronic records and human review interfaces.

Potential decision output

A proposed control strategy and monitoring plan.

No system would be described as validated or suitable for release without the required evidence and authority.
04
Activity

Packaging and transfer study

What happens

Teams could examine container compatibility, protection, labelling, traceability, storage and movement requirements.

Illustrative system categories

Packaging prototypes, seal and integrity testing, inspection tools, temperature monitoring and transfer documentation.

Potential decision output

A packaging brief and receiving site transfer package.

Patient facing, release and distribution activities would require applicable approvals and authorised organisations.

Innovation architecture

A modular manufacturing knowledge platform.

The proposed innovation model would connect flexible physical modules with process monitoring, electronic records and disciplined human decisions. It would not treat automation or modularity as a substitute for quality systems and legal authority.

  1. 01

    Configurable process environments

    Common services could support product-specific modules only after scope, demand and containment needs were proven.

    Potential outputCapacity that follows evidence
  2. 02

    Connected process understanding

    Material attributes, operating parameters and quality observations could be reviewed as one transfer story.

    Potential outputA stronger control and transfer rationale
  3. 03

    Digital records with human authority

    Electronic records and monitoring could improve traceability. Appropriately authorised organisations and personnel would retain review, certification and release responsibilities where applicable.

    Potential outputObservable and accountable operations
InputProduct and process requirements

Formulation, quality attributes, demand and intended scale.

Controlled workProcess learning

Unit operations, scale models, controls, packaging and logistics.

DecisionCapacity gate

Configure, transfer outside the campus, redesign or stop.

HandoffTransfer package

Parameters, controls, risks, records and receiving needs.

For the public reader

What this could mean for Scotland.

Potential value for advanced manufacturing and local supply chains in Scotland.

This building could help teams understand whether a defined product process can become repeatable and transferable before committing to larger capacity. Local benefit would depend on real products, lawful operations and a commercially credible plan.

01

Potential route from laboratory recipes to repeatable processes

Teams could study how a medicine behaves as production increases, including mixing, control, packaging and storage.

What must be true

Defined products, suitable utilities, qualified people, quality systems and authorisation.

02

Potential contribution to selected medicine supply resilience

For suitable products, local process knowledge could create more future supply options.

What must be true

Validated demand, licensed operations, qualified suppliers and a realistic economic case.

03

Potential skilled manufacturing careers

Future work could span process science, engineering, automation, quality, maintenance and technical operations.

What must be true

Funded roles, fair recruitment, sustained demand and training partnerships.

04

Potential demand for Scottish suppliers

A future facility could need engineering, controlled environment services, logistics, calibration, packaging and maintenance.

What must be true

Competitive procurement, supplier qualification and operating demand.

Conditional outcomes

These are potential outcomes, not current impacts. Delivery depends on funded demand, permissions, qualified operators, formal partners, safe operating systems and a credible commercial plan.

From concept to an operating case

Value requires a route to users, the wider campus and proof.

Potential operating routes

01

Process development programmes

Defined work to understand and improve a product-specific process.

02

Engineering and pilot activity

Future activity only where authorisation, quality systems, operator responsibility and demand support it.

03

Technology transfer and packaging

Controlled knowledge, packaging and logistics planning for qualified supply routes.

Connected campus

ReceivesFormulation & Analytical Sciences

Formulation requirements, analytical methods and material risks.

ReceivesAI, Robotics & Digital Operations

Simulation, automation and governed operational data concepts.

ReceivesQuality, Data & Regulatory

Quality authority, controlled records and regulatory route assumptions.

Evidence required before delivery

This environment advances only when the operating case is stronger than the concept.

  1. 01

    Defined product, dosage form and batch scope

  2. 02

    Credible demand, capacity logic and accountable operator

  3. 03

    Utilities, containment, validation and quality system design

  4. 04

    Licensing route, qualified leadership, safety case and finance

Reference context

These links provide background to selected technical or policy concepts. They do not substantiate delivery, endorse VARUNÉ Labs or prove current capability or regional impact.

MHRA manufacturing and distribution guidanceICH quality guidelines